Skip to main content
Skip to section navigation
Skip to footer
News
Careers
Contact us
Medical Information
About Us
Overview
Management Team
Board of Directors
Compliance and Transparency
Pipeline & Portfolio
Pipeline
Our Therapies
Science
Overview
Publications
Clinical Trials
Investors
Overview
News
Events & Presentations
Stock Info
Financials & Filings
Governance
IR Resources
News
Careers
Contact us
Medical Information
SEC Filings
Investors
Investors
Overview
News
Press Releases
Email Alerts
Events & Presentations
Events
Presentations
Stock Info
Quote and Chart
Historical Performance
Analyst Coverage
Financials & Filings
Financial Results
SEC Filings
Annual Reports
Email Alerts
Governance
Overview
Governance Documents
Management Team
Board of Directors
Board Committees
IR Resources
Investor FAQs
Email Alerts
Contacts
Filing Type:
View All
10-K
10-Q
144
20-F
3
4
424B4
424B5
424B7
6-K
6-K/A
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DRS
DRS/A
EFFECT
F-1
F-1/A
F-1MEF
F-3ASR
F-6
F-6/A
PRE 14A
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SEC STAFF LETTER
UPLOAD
Year:
View All
2024
2023
2022
2021
2020
2016
Date
Form
Description
PDF
XBRL
Pages
08/10/22
6-K
Form 6-K: Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
08/10/22 6-K Documents
expand_more
EX-99.1
EX-99.2
EX-99.3
EX-99.4
70
07/28/22
D
Form D: Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act.
5
07/21/22
SC 13D
Form SC 13D: Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities
07/21/22 SC 13D Documents
expand_more
EX-99.1
EX-99.2
EX-99.3
EX-99.4
65
07/20/22
6-K
Form 6-K: Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
07/20/22 6-K Documents
expand_more
EX-99.1
EX-99.2
EX-99.3
60
07/20/22
SC 13D/A
Form SC 13D/A: Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities
07/20/22 SC 13D/A Documents
expand_more
EX-99.2
8
07/11/22
6-K
Form 6-K: Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
07/11/22 6-K Documents
expand_more
EX-99.1
7
06/27/22
6-K
Form 6-K: Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
06/27/22 6-K Documents
expand_more
EX-99.1
7
06/09/22
6-K
Form 6-K: Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
06/09/22 6-K Documents
expand_more
EX-99.1
7
06/08/22
6-K
Form 6-K: Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
06/08/22 6-K Documents
expand_more
EX-99.1
9
06/06/22
6-K
Form 6-K: Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
06/06/22 6-K Documents
expand_more
EX-99.1
8
rss_feed
Filing RSS
Previous Page
arrow_back
Page
1
…
Page
8
Page
9
Page
10
Page
11
Page
12
Page
13
Page
14
Page
15
Page
16
Page
17
…
Page
19
Next Page
arrow_forward
Select a page:
Page 1
Page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
Page 10
Page 11
Page 12
Page 13
Page 14
Page 15
Page 16
Page 17
Page 18
Page 19
email
Email Alerts
contact_page
Contacts
rss_feed
RSS News Feed
account_tree
Sitemap